These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies. Yu Q, Spatz S, Li Y, Yang J, Zhao W, Zhang Z, Wen G, Garcia M, Zsak L. Vaccine; 2017 Feb 01; 35(5):789-795. PubMed ID: 28052812 [Abstract] [Full Text] [Related]
3. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens. Kanabagatte Basavarajappa M, Kumar S, Khattar SK, Gebreluul GT, Paldurai A, Samal SK. Vaccine; 2014 Jun 12; 32(28):3555-63. PubMed ID: 24793943 [Abstract] [Full Text] [Related]
4. Spray vaccination with a Newcastle disease virus (NDV)-vectored infectious laryngotracheitis (ILT) vaccine protects commercial chickens from ILT in the presence of maternally-derived antibodies. Zeng Z, Wang Z, Wang X, Yao L, Shang Y, Feng H, Wang H, Shao H, Luo Q, Wen G. Avian Pathol; 2024 Dec 12; 53(6):533-539. PubMed ID: 38836447 [Abstract] [Full Text] [Related]
5. Generation of Newcastle Disease Virus (NDV) Recombinants Expressing the Infectious Laryngotracheitis Virus (ILTV) Glycoprotein gB or gD as Dual Vaccines. Zhao W, Spatz S, Zsak L, Yu Q. Methods Mol Biol; 2016 Dec 12; 1404():89-101. PubMed ID: 27076292 [Abstract] [Full Text] [Related]
6. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus. Wei X, Shao Y, Han Z, Sun J, Liu S. Vet Microbiol; 2020 Nov 12; 250():108835. PubMed ID: 33011664 [Abstract] [Full Text] [Related]
9. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers. Palomino-Tapia VA, Zavala G, Cheng S, García M. Avian Pathol; 2019 Jun 12; 48(3):209-220. PubMed ID: 30640536 [Abstract] [Full Text] [Related]
13. Protection against infectious laryngotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines. Johnson DI, Vagnozzi A, Dorea F, Riblet SM, Mundt A, Zavala G, García M. Avian Dis; 2010 Dec 12; 54(4):1251-9. PubMed ID: 21313847 [Abstract] [Full Text] [Related]
16. Characterization of a Recombinant Thermostable Newcastle Disease Virus (NDV) Expressing Glycoprotein gB of Infectious Laryngotracheitis Virus (ILTV) Protects Chickens against ILTV Challenge. Zeng Z, He Y, Wang Z, Yao L, Li L, Shang Y, Wang H, Zhang R, Shao H, Luo Q, Wen G. Viruses; 2023 Feb 11; 15(2):. PubMed ID: 36851714 [Abstract] [Full Text] [Related]
17. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine. Esaki M, Godoy A, Rosenberger JK, Rosenberger SC, Gardin Y, Yasuda A, Dorsey KM. Avian Dis; 2013 Dec 11; 57(4):750-5. PubMed ID: 24597117 [Abstract] [Full Text] [Related]